Clinical genomics of cancer, with a paricular focus on the epigenetics of breast cancer and translational nanodiagnostics

​Over the past 5 years Darren has focused on the epigenetics of breast cancer, and in particular  the unique molecular profile of this disease can be exploited. By interrogating the DNA methlyation state of this disease, Darren has worked collaboratively with national and international teams to attempt to identify biomarkers of disease which can be used to determine response to cancer therapy, how likely the individual is to survive their disease, and is currently applying this research to the early detection of all cancers.

​Darren received his PhD from the Institute for Molecular Bioscience, at the University of Queensland, under the supervision of Professor John Mattick. Since graduation he has been employed full-time at the Australian Institute for Bioengineering and Nanotechnology (AIBN), where he is currently Head of Sequencing for the Centre for Personalised Medicine.


​Darren has collaborated nationally and internatonally with rearchers in at the Garvan Institute, Newcastle University, Queen Mary's University London, and others.


​2017 UQ ECR grant
2016 UQ and NHMRC MEI Equipment grant
2013 UQ and NHMRC MEI Equipment grant